secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXACT SCIENCES CORP (—)
CIK:        0001124140
Form:       8-K
Filed at:   2025-01-06T23:59:59+00:00
Accession:  0001124140-25-000003
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Exact Sciences appoints Kim Popovits to Board of Directors
----------------------------------------------------------

- Board expanded from 9 to 10 members; Popovits appointed Class I director, term ends at 2025 annual meeting.
- Popovits previously served as President and CEO of Genomic Health until Exact Sciences' 2019 acquisition.
- She brings over 40 years healthcare experience, including leadership roles at Genentech and Genomic Health.
- Received initial stock award valued at $375,000 per non-employee director compensation policy.
- Currently serves on boards of Kiniksa Pharmaceuticals, 10x Genomics, and Talis Biomedical.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1124140/000112414025000003/0001124140-25-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1124140/000112414025000003/exas-20250102.htm
  HTML page:      https://secwatch.observer/filing/0001124140-25-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer